Zealand Pharma A/S (ZEAL) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ZEAL is $29.00, representing a +64.9% upside from the current price of $17.59. Price targets range from a low of $26.00 to a high of $32.00.
